153 related articles for article (PubMed ID: 21625227)
1. Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT.
Kakihana K; Ohashi K; Murata Y; Tsubokura M; Kobayashi T; Yamashita T; Sakamaki H; Akiyama H
Bone Marrow Transplant; 2012 Apr; 47(4):593-5. PubMed ID: 21625227
[No Abstract] [Full Text] [Related]
2. Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation.
Fujii N; Ikeda K; Koyama M; Aoyama K; Masunari T; Kondo E; Matsuzaki T; Mizobuchi S; Hiraki A; Teshima T; Shinagawa K; Ishimaru F; Tanimoto M
Int J Hematol; 2006 Jun; 83(5):459-61. PubMed ID: 16787880
[TBL] [Abstract][Full Text] [Related]
3. Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.
Oshima K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Kanda Y
Bone Marrow Transplant; 2010 Apr; 45(4):781-2. PubMed ID: 19701249
[No Abstract] [Full Text] [Related]
4. Calcineurin-inhibitor pain syndrome following haematopoietic stem cell transplantation.
Kida A; Ohashi K; Tanaka C; Kamata N; Akiyama H; Sakamaki H
Br J Haematol; 2004 Aug; 126(3):288. PubMed ID: 15257699
[No Abstract] [Full Text] [Related]
5. [Retrospective analysis of posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation].
Aisa Y; Mori T; Shimizu T; Tsukada Y; Kato J; Suzuki S; Suzuki N; Ikeda Y; Okamoto S
Rinsho Ketsueki; 2009 Jan; 50(1):9-15. PubMed ID: 19225223
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin-inhibitor induced pain syndrome after organ transplantation.
Collini A; De Bartolomeis C; Barni R; Ruggieri G; Bernini M; Carmellini M
Kidney Int; 2006 Oct; 70(7):1367-70. PubMed ID: 16955101
[No Abstract] [Full Text] [Related]
7. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
[TBL] [Abstract][Full Text] [Related]
8. Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases.
Nasu R; Nannya Y; Shinohara A; Ichikawa M; Kurokawa M
Ann Hematol; 2014 Jul; 93(7):1215-23. PubMed ID: 24590535
[TBL] [Abstract][Full Text] [Related]
9. [Second transplantation for graft failure after allogeneic hematopoietic stem cell transplantation--a retrospective survey by Kanto Study Group for Cell Therapy].
Hagihara M; Kanamori H; Sakai M; Mori T; Nakaseko C; Aotsuka N; Uehara T; Sakura T; Yoshiba F; Kawai N; Tanaka M; Fujisawa S; Ohwada C; Wakita H; Yokota A; Kawamura T; Maruta A; Sakamaki H; Okamoto S;
Rinsho Ketsueki; 2010 Jun; 51(6):390-7. PubMed ID: 20622484
[TBL] [Abstract][Full Text] [Related]
10. Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
Miyakoshi S; Kusumi E; Matsumura T; Hori A; Murashige N; Hamaki T; Yuji K; Uchida N; Masuoka K; Wake A; Kanda Y; Kami M; Tanaka Y; Taniguchi S
Biol Blood Marrow Transplant; 2007 Jul; 13(7):771-7. PubMed ID: 17580255
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide.
Castagna L; Bramanti S; Furst S; Giordano L; Sarina B; Crocchiolo R; El-Cheikh J; Granata A; Morabito L; Mauro E; Faucher C; Mohty B; Harbi S; Devillier R; Chabannon C; Carlo-Stella C; Santoro A; Blaise D
Bone Marrow Transplant; 2016 Mar; 51(3):462-5. PubMed ID: 26595078
[No Abstract] [Full Text] [Related]
12. Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
Chohan R; Vij R; Adkins D; Blum W; Brown R; Tomasson M; Devine S; Graubert T; Goodnough LT; DiPersio JF; Khoury H
Br J Haematol; 2003 Oct; 123(1):110-3. PubMed ID: 14510951
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of calcineurin inhibitor-induced pain syndrome with acute graft versus host disease by switching calcineurin inhibitors followed by pregabalin.
Watanabe M; Koba Y; Tamekane A
Ann Hematol; 2017 Jul; 96(7):1207-1208. PubMed ID: 28508935
[No Abstract] [Full Text] [Related]
14. Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion.
Torelli GF; Natalino F; Barberi W; Iori AP; Andreoli C; Valle V; Mercanti C; Perrone S; Gualdi G; Foà R
Leuk Res; 2011 Oct; 35(10):1423-4. PubMed ID: 21397327
[No Abstract] [Full Text] [Related]
15. Effect of early posttransplantation tacrolimus concentration on the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors.
Mori T; Kato J; Shimizu T; Aisa Y; Nakazato T; Yamane A; Ono Y; Kunimoto H; Okamoto S
Biol Blood Marrow Transplant; 2012 Feb; 18(2):229-34. PubMed ID: 21708109
[TBL] [Abstract][Full Text] [Related]
16. Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation.
Saburi M; Kohashi S; Kato J; Koda Y; Sakurai M; Toyama T; Kikuchi T; Karigane D; Yuda S; Yamane Y; Hashida R; Abe R; Nakazato T; Hirahashi J; Ogata M; Okamoto S; Mori T
Int J Hematol; 2017 Sep; 106(3):431-435. PubMed ID: 28516402
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ
J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
[TBL] [Abstract][Full Text] [Related]
18. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
Hanto DW; Chudzinski R
Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
[No Abstract] [Full Text] [Related]
19. Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.
Wingard JR; Nash RA; Przepiorka D; Klein JL; Weisdorf DJ; Fay JW; Zhu J; Maher RM; Fitzsimmons WE; Ratanatharathorn V
Biol Blood Marrow Transplant; 1998; 4(3):157-63. PubMed ID: 9923414
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.
Ringdén O; Remberger M; Dahllöf G; Garming-Legert K; Karlsson H; Svenberg P; Uhlin M; Uzunel M; Mattsson J
Eur J Haematol; 2011 Dec; 87(6):503-9. PubMed ID: 22974354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
